Related Experiment Videos
Mucosa-associated lymphoid tissue (MALT) lymphoma
1Section of Hematology and Stem Cell Transplantation, Rush University Medical Center, Chicago, IL, USA. Sharon_D_manson@rush.edu
Seminars in Oncology Nursing
|May 25, 2006
Summary
This review covers Mucosa-Associated Lymphoid Tissue (MALT) lymphoma, a unique non-Hodgkin's lymphoma. Early MALT lymphoma treatment involves H. pylori eradication or radiotherapy, with chemotherapy for advanced cases.
Area of Science:
- Oncology
- Pathology
- Immunology
Background:
- Mucosa-Associated Lymphoid Tissue (MALT) lymphoma is a distinct extranodal non-Hodgkin's lymphoma.
- While commonly affecting the gastrointestinal tract, MALT lymphoma can manifest in various organ systems.
- Helicobacter pylori infection is strongly associated with gastric MALT lymphoma pathogenesis.
Purpose of the Study:
- To review the pathogenesis of MALT lymphoma.
- To explore the associations between MALT lymphoma and antigenic stimulation.
- To discuss the unique presentation and treatment strategies for MALT lymphoma.
Main Methods:
- Comprehensive review of research articles.
- Synthesis of information from medical textbooks.
- Analysis of existing literature on MALT lymphoma.
Main Results:
- MALT lymphoma is a heterogeneous extranodal B-cell non-Hodgkin's lymphoma.
- Gastric MALT lymphomas are frequently linked to H. pylori infection.
- Early-stage MALT lymphoma can be treated with H. pylori eradication and/or radiotherapy, potentially leading to cure.
Conclusions:
- Treatment for advanced or resistant MALT lymphoma typically involves chemotherapy.
- Nurses are vital in patient education regarding MALT lymphoma and therapy compliance.
- Addressing patients' social needs is crucial for effective MALT lymphoma management.